GoHealth (GOCO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual Meeting scheduled for June 17, 2026, will be held virtually, allowing shareholders to vote and submit questions online.
Record date for voting is April 22, 2026; all holders of Series A Preferred, Class A, and Class B common stock as of this date are eligible to vote.
Proxy materials and annual report are available online, with multiple voting methods provided (internet, phone, mail, or during the meeting).
Voting matters and shareholder proposals
Three Class III Directors (Clinton P. Jones, Bao Truong, William L. Transier) nominated for election to serve until 2029.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (Say-on-Pay) for named executive officers.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine members, divided into three staggered classes with three-year terms.
Recent board changes include appointments and resignations tied to a credit agreement; a Transformation Committee was established.
Controlled company exemptions are utilized, allowing deviation from some Nasdaq governance standards.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Transformation, each with defined responsibilities.
Majority of directors are independent per Nasdaq rules; independence reviewed annually.
Latest events from GoHealth
- Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.GOCO
Proxy filing30 Apr 2026 - Net revenues fell 54.7% and net loss reached $497.8M amid strategic pullback and major impairments.GOCO
Q4 202531 Mar 2026 - Record Medicare Advantage disruption fuels growth for a tech-driven, unbiased enrollment leader.GOCO
2024 Southwest IDEAS Conference3 Feb 2026 - Operational innovation and acquisitions fueled a dramatic financial turnaround and market leadership.GOCO
17th Annual LD Micro Main Event Conference3 Feb 2026 - Personalized tech, SNP focus, and unbiased plan fit drive growth as market disruption rises.GOCO
Noble Capital Consumer, Communications, Media, and Technology Emerging Growth Equity Conference3 Feb 2026 - Tech-driven Medicare Advantage model delivers growth, efficiency, and positive cash flow.GOCO
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 2024 revenue fell 25.9% to $105.9M, net loss up to $59.3M, with H2 growth expected.GOCO
Q2 20242 Feb 2026 - Tech-enabled, unbiased plan matching and financial discipline drive growth amid Medicare market shifts.GOCO
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - AI-powered Medicare marketplace drives growth, retention, and efficiency with health plan partnerships.GOCO
15th Annual Midwest IDEAS Investor Conference23 Jan 2026